Diseases Covered

Myeloproliferative Diseases

Includes: Hypereosinophilic Syndrome, Myelofibrosis, Essential Thrombocytosis, Polycythemia vera
All pictures shown are used for illustrative purposes only.

Program Status

open

Apply Now

We encourage you to apply for assistance; see the qualifications below.
 

Assistance Amount

$ 6,500

Ask your Good Days Patient Care Navigator for more information.

Eligibility Criteria

  • Patient must be diagnosed with a covered disease and program must be accepting enrollments
  • Patient must have a valid Social Security number to apply for assistance and receive treatment in the United States
  • Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis
  • Patient is required to have valid Medicare or Military insurance coverage
  • Patient income level must be at or below 500% of the Federal Poverty Level (FPL)

Apply Now

  • Agrylin
  • Anagrelide
  • Droxia/Hydrea
  • Gleevec
  • Hydrea
  • Hydroxyurea
  • Imatinib Mesylate
  • Inrebic
  • Jakafi

Chronic myeloproliferative neoplasms are diseases in which the bone marrow makes too many red blood cells, platelets, or certain white blood cells. (Source: NIH; National Cancer Institute)

Medications Covered

  • Agrylin
  • Anagrelide
  • Droxia/Hydrea
  • Gleevec
  • Hydrea
  • Hydroxyurea
  • Imatinib Mesylate
  • Inrebic
  • Jakafi

Disease Description

Chronic myeloproliferative neoplasms are diseases in which the bone marrow makes too many red blood cells, platelets, or certain white blood cells. (Source: NIH; National Cancer Institute)

Apply For Assistance

Speeding your treatment is important to us.
Arrow

Get Our Newsletter

You're not alone. The Good Days newsletter keeps you up-to-date.
Arrow

Helpful Links